Proteomics International Laboratories has sealed a new deal with medical diagnostics company Eurobio Scientific to distribute its predictive “PromarkerD” test for diabetic kidney disease (DKD) in France.
Under the five-year deal, with an option to extend for a further five years, Proteomics will receive a payment for each PromarkerD kit sold. The company says further details of the agreement are commercially sensitive and confidential.